Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Thomas

Showing results (101-110 of 217) with videos related to

Pageof 22
Sort By:
Cancer Research|September 3, 2009
Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situNicholas I Fleming, Melanie K Trivett, Joshy George, et al.
Drug Discovery Today|October 24, 2015
Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicineDavid M Thomas, Stephen Fox, Paula K Lorgelly, et al.
Emergency Radiology|December 13, 2018
Evaluation of the proximal coronary arteries in suspected pulmonary embolism: diagnostic images in 51% of patients using non-gated, dual-source CT pulmonary angiographyDavid M Thomas, Patrick D McLaughlin, James P Nugent, et al.
Journal of Neurochemistry|December 24, 2011
Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatumMariana Angoa-Pérez, Michael J Kane, Dina M Francescutti, et al.
Clinical and Translational Medicine|April 17, 2024
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databasesImogen R Walpole, Farzana Y Zaman, Peinan Zhao, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness?Don Husereau, Lotte Steuten, Vivek Muthu, et al.
Journal of Neurochemistry|December 5, 2012
Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMAMariana Angoa-Pérez, Michael J Kane, Denise I Briggs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 26, 2021
Fear of cancer recurrence in patients undergoing germline genome sequencingNicci Bartley, Grace Davies, Phyllis Butow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 9, 2022
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative studyMegan C Best, Nicci Bartley, Christine E Napier, et al.
Genome Research|April 6, 2018
Optical mapping reveals a higher level of genomic architecture of chained fusions in cancerEva K F Chan, Daniel L Cameron, Desiree C Petersen, et al.
Pageof 22

Showing results (101-110 of 217) with videos related to

Sort By:
Pageof 22
Cancer Research|September 3, 2009
Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situNicholas I Fleming, Melanie K Trivett, Joshy George, et al.
Drug Discovery Today|October 24, 2015
Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicineDavid M Thomas, Stephen Fox, Paula K Lorgelly, et al.
Emergency Radiology|December 13, 2018
Evaluation of the proximal coronary arteries in suspected pulmonary embolism: diagnostic images in 51% of patients using non-gated, dual-source CT pulmonary angiographyDavid M Thomas, Patrick D McLaughlin, James P Nugent, et al.
Journal of Neurochemistry|December 24, 2011
Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatumMariana Angoa-Pérez, Michael J Kane, Dina M Francescutti, et al.
Clinical and Translational Medicine|April 17, 2024
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databasesImogen R Walpole, Farzana Y Zaman, Peinan Zhao, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness?Don Husereau, Lotte Steuten, Vivek Muthu, et al.
Journal of Neurochemistry|December 5, 2012
Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMAMariana Angoa-Pérez, Michael J Kane, Denise I Briggs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 26, 2021
Fear of cancer recurrence in patients undergoing germline genome sequencingNicci Bartley, Grace Davies, Phyllis Butow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 9, 2022
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative studyMegan C Best, Nicci Bartley, Christine E Napier, et al.
Genome Research|April 6, 2018
Optical mapping reveals a higher level of genomic architecture of chained fusions in cancerEva K F Chan, Daniel L Cameron, Desiree C Petersen, et al.
Pageof 22